Michael Föller, Manuel Braun, Syed M Qadri, Elisabeth Lang, Hasan Mahmud, Florian Lang
Index: Eur. J. Clin. Invest. 40(6) , 534-40, (2010)
Full Text: HTML
Fever and hyperthermia are frequently associated with anaemia. Under most clinical conditions, they are considered to be two mutually independent clinical consequences of a common cause. The present study explored the possibility that anaemia results from temperature-sensitive suicidal erythrocyte death or eryptosis. Eryptosis is characterised by cell shrinkage and cell membrane scrambling with phosphatidylserine (PS) exposure at the erythrocyte surface. It is triggered by increase in the cytosolic Ca(2+) activity on the one hand and by ceramide formation on the other.Annexin V-binding was utilised to disclose PS exposure, forward scatter to analyse cell volume, Fluo 3 fluorescence to estimate cytosolic Ca(2+) activity, binding of fluorescent antibodies to determine ceramide abundance and a luciferin/luciferase-based assay to measure the cytosolic ATP concentration.Graded increases in temperature from 37 to 41 degrees C decreased the forward scatter and stimulated annexin V-binding of human erythrocytes. The effect was accompanied by increased cytosolic Ca(2+) activity, decrease of the cellular ATP content and a moderate rise in ceramide formation. The effect of hyperthermia on annexin V-binding was significantly blunted by the leukotriene receptor CysLT1 antagonist cinalukast (1 microM).Hyperthermia stimulates Ca(2+) entry into erythrocytes leading to cell shrinkage and PS exposure. As PS-exposing erythrocytes are rapidly cleared from circulating blood, the eryptosis during hyperthermia may cause anaemia.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Cinalukast
CAS:128312-51-6 |
C23H28N2O3S |
Participation of leukotriene C(4) in the regulation of suici...
2009-09-01 [J. Physiol. Pharmacol. 60(3) , 135-43, (2009)] |
Prolonged protection against exercise-induced bronchoconstri...
1997-02-01 [J. Allergy Clin. Immunol. 99(2) , 210-5, (1997)] |
Heterogeneity of binding sites for ICI 198,615 in human lung...
1992-10-06 [Biochem. Pharmacol. 44(7) , 1411-5, (1992)] |
Pharmacologic actions of Ro 24-5913, a novel antagonist of l...
1991-11-01 [J. Pharmacol. Exp. Ther. 259(2) , 751-8, (1991)] |
Synergism exhibited by LTD4 and PAF receptor antagonists in ...
1995-01-01 [Adv. Prostaglandin. Thromboxane. Leukot. Res. 23 , 271-3, (1995)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved